Skip to search formSkip to main contentSkip to account menu

Chelation Therapy

Known as: Therapy, Chelation, therapy chelation, Therapies, Chelation 
Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (2)

ChemotherapyPharmacotherapy
DeferoxamineIron Chelating Agentsnursing therapystandards characteristics

Narrower (1)

iron chelation therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Prevalence of hepatitis C virus infection among thalassemia patients: a perspective from a multi-ethnic population of Pakistan.
Highly Cited
2012
Highly Cited
2012
Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.
2011
2011
Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
Highly Cited
2007
Highly Cited
2007
Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670)
Transfusional iron overload in patients with chronic anemias can result in multiple organ failure. Experience in the management… 
Highly Cited
2007
Highly Cited
2007
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.
BACKGROUND Deferasirox is a recently approved once-daily oral iron chelator that has been shown to reduce liver iron… 
Review
2006
Review
2006
Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity.
2005
2005
Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: synthesis, characterization, and biological evaluation.
Iron overload is a severe clinical condition and can be largely prevented by the use of iron-specific chelating agents. A… 
Review
2001
Review
2001
Consensus document for transfusion-related iron overload.
  • E. Vichinsky
  • Seminars in hematology (Print)
  • 2001
  • Corpus ID: 45077060
1983
1983
Minimal role of metallothionein in decreased chelator efficacy for cadmium.
1981
1981
Response to long-term deferoxamine therapy in thalassemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)